Last reviewed · How we verify
Ticagrelor Oral Tablet - Pre-Treatment
Ticagrelor Oral Tablet - Pre-Treatment is a Small molecule drug developed by SFJ Pharmaceuticals, Inc.. It is currently in Phase 2 development.
At a glance
| Generic name | Ticagrelor Oral Tablet - Pre-Treatment |
|---|---|
| Sponsor | SFJ Pharmaceuticals, Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial Infarction (PHASE4)
- Study to Evaluate the Safety, Tolerability, PK, and PD of PB2452 in Healthy Volunteers (PHASE1)
- Study to Evaluate the Safety, Tolerability, PK and PD of PB2452 in Healthy Younger, Older and Elderly Subjects (PHASE2)
- Phase 2B Study to Evaluate the Efficacy of Bentracimab (PB2452) in Reversal of Ticagrelor in Subjects Aged 50-80 Years Old (PHASE2)
- Study to Evaluate the Safety, Tolerability, PK, and PD of PB2452 With and Without Ticagrelor Pretreatment in Chinese Healthy Volunteers (PHASE1)
- Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting (PHASE3)
- Pharmacokinetics, Pharmacodynamics, and Safety Study of Ticagrelor in Hemodialysis Patients and Healthy Subjects (PHASE1)
- Evaluation of Antiplatelet Effects and Safety of Intraoperative Administration of Ticagrelor Versus Clopidogrel (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ticagrelor Oral Tablet - Pre-Treatment CI brief — competitive landscape report
- Ticagrelor Oral Tablet - Pre-Treatment updates RSS · CI watch RSS
- SFJ Pharmaceuticals, Inc. portfolio CI
Frequently asked questions about Ticagrelor Oral Tablet - Pre-Treatment
What is Ticagrelor Oral Tablet - Pre-Treatment?
Ticagrelor Oral Tablet - Pre-Treatment is a Small molecule drug developed by SFJ Pharmaceuticals, Inc..
Who makes Ticagrelor Oral Tablet - Pre-Treatment?
Ticagrelor Oral Tablet - Pre-Treatment is developed by SFJ Pharmaceuticals, Inc. (see full SFJ Pharmaceuticals, Inc. pipeline at /company/sfj-pharmaceuticals-inc).
What development phase is Ticagrelor Oral Tablet - Pre-Treatment in?
Ticagrelor Oral Tablet - Pre-Treatment is in Phase 2.